|
1
|
Fisher JL, Schwartzbaum JA, Wrensch M and
Wiemels JL: Epidemiology of brain tumors. Neurol Clin. 25:867–890.
vii2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Little MP, de Vathaire F, Shamsaldin A, et
al: Risks of brain tumour following treatment for cancer in
childhood: modification by genetic factors, radiotherapy and
chemotherapy. Int J Cancer. 78:269–275. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bondy ML, Wang LE, El-Zein R, et al:
Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst.
93:1553–1557. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang G, Li X, Huang F, et al: Antitumor
effect of beta-elemene in non-small-cell lung cancer cells is
mediated via induction of cell cycle arrest and apoptotic cell
death. Cell Mol Life Sci. 62:881–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Deng Y, Mao S, Jin S, Wang J and
Bi D: Characterization and body distribution of beta-elemene solid
lipid nanoparticles (SLN). Drug Dev Ind Pharm. 31:769–778. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li X, Wang G, Zhao J, et al:
Antiproliferative effect of beta-elemene in chemoresistant ovarian
carcinoma cells is mediated through arrest of the cell cycle at the
G2-M phase. Cell Mol Life Sci. 62:894–904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie CY, Yang W, Li M, et al: Cell
apoptosis induced by delta-elemene in colorectal adenocarcinoma
cells via a mitochondrial-mediated pathway. Yakugaku Zasshi.
129:1403–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sasaki K, Tsuno NH, Sunami E, et al:
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on
colon cancer cells. BMC Cancer. 10:3702010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mesri M, Wall NR, Li J, Kim RW and Altieri
DC: Cancer gene therapy using a survivin mutant adenovirus. J Clin
Invest. 108:981–990. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Das A, Tan WL, Teo J and Smith DR:
Expression of survivin in primary glioblastomas. J Cancer Res Clin
Oncol. 128:302–306. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Holcik M, Gibson H and Korneluk RG: XIAP:
apoptotic brake and promising therapeutic target. Apoptosis.
6:253–261. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holcik M and Korneluk RG: XIAP, the
guardian angel. Nat Rev Mol Cell Biol. 2:550–556. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song Z, Yao X and Wu M: Direct interaction
between survivin and Smac/DIABLO is essential for the
anti-apoptotic activity of survivin during taxol-induced apoptosis.
J Biol Chem. 278:23130–23140. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu T, Brouha B and Grossman D: Rapid
induction of mitochondrial events and caspase-independent apoptosis
in Survivin-targeted melanoma cells. Oncogene. 23:39–48. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Uren AG, Wong L, Pakusch M, et al:
Survivin and the inner centromere protein INCENP show similar
cell-cycle localization and gene knockout phenotype. Curr Biol.
10:1319–1328. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fraser AG, James C, Evan GI and Hengartner
MO: Caenorhabditis elegans inhibitor of apoptosis protein (IAP)
homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol.
9:292–301. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Speliotes EK, Uren A, Vaux D and Horvitz
HR: The survivin-like C. elegans BIR-1 protein acts with the
Aurora-like kinase AIR-2 to affect chromosomes and the spindle
midzone. Mol Cell. 6:211–223. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Temme A, Rieger M, Reber F, et al:
Localization, dynamics, and function of survivin revealed by
expression of functional survivinDsRed fusion proteins in the
living cell. Mol Biol Cell. 14:78–92. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liston P, Young SS, Mackenzie AE and
Korneluk RG: Life and death decisions: the role of the IAPs in
modulating programmed cell death. Apoptosis. 2:423–441. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Melegari M, Scaglioni PP and Wands JR:
Cloning and characterization of a novel hepatitis B virus x binding
protein that inhibits viral replication. J Virol. 72:1737–1743.
1998.PubMed/NCBI
|
|
23
|
Marusawa H, Matsuzawa S, Welsh K, et al:
HBXIP functions as a cofactor of survivin in apoptosis suppression.
EMBO J. 22:2729–2740. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paydas S, Tanriverdi K, Yavuz S, Disel U,
Sahin B and Burgut R: Survivin and aven: two distinct antiapoptotic
signals in acute leukemias. Ann Oncol. 14:1045–1050. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grossman D, Kim PJ, Blanc-Brude OP, et al:
Transgenic expression of survivin in keratinocytes counteracts
UVB-induced apoptosis and cooperates with loss of p53. J Clin
Invest. 108:991–999. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shin S, Sung BJ, Cho YS, et al: An
anti-apoptotic protein human survivin is a direct inhibitor of
caspase-3 and -7. Biochemistry. 40:1117–1123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chandele A, Prasad V, Jagtap JC, Shukla R
and Shastry PR: Upregulation of survivin in G2/M cells and
inhibition of caspase 9 activity enhances resistance in
staurosporine-induced apoptosis. Neoplasia. 6:29–40. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li QQ, Wang G, Zhang M, Cuff CF, Huang L
and Reed E: Beta-Elemene, a novel plant-derived antineoplastic
agent, increases cisplatin chemosensitivity of lung tumor cells by
triggering apoptosis. Oncol Rep. 22:161–170. 2009.
|
|
29
|
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ
and Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells
depends on p38 MAPK activation. Cancer Lett. 264:127–134. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thornberry NA and Lazebnik Y: Caspases:
enemies within. Science. 281:1312–1316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ashkenazi A and Dixit VM: Apoptosis
control by death and decoy receptors. Curr Opin Cell Biol.
11:255–260. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li P, Nijhawan D, Budihardjo I, et al:
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9
complex initiates an apoptotic protease cascade. Cell. 91:479–489.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zou H, Li Y, Liu X and Wang X: An APAF-1.
cytochrome c multimeric complex is a functional apoptosome that
activates procaspase-9. J Biol Chem. 274:11549–11556. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Senderowicz AM: Cell cycle modulators for
the treatment of lung malignancies. Clin Lung Cancer. 5:158–168.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Swana HS, Grossman D, Anthony JN, Weiss RM
and Altieri DC: Tumor content of the antiapoptosis molecule
survivin and recurrence of bladder cancer. N Engl J Med.
341:452–453. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Okada E, Murai Y, Matsui K, et al:
Survivin expression in tumor cell nuclei is predictive of a
favorable prognosis in gastric cancer patients. Cancer Lett.
163:109–116. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ito T, Shiraki K, Sugimoto K, et al:
Survivin promotes cell proliferation in human hepatocellular
carcinoma. Hepatology. 31:1080–1085. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kawasaki H, Toyoda M, Shinohara H, et al:
Expression of survivin correlates with apoptosis, proliferation,
and angiogenesis during human colorectal tumorigenesis. Cancer.
91:2026–2032. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Adida C, Berrebi D, Peuchmaur M,
Reyes-Mugica M and Altieri DC: Anti-apoptosis gene, survivin, and
prognosis of neuroblastoma. Lancet. 351:882–883. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chakravarti A, Noll E, Black PM, et al:
Quantitatively determined survivin expression levels are of
prognostic value in human gliomas. J Clin Oncol. 20:1063–1068.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tamm I, Wang Y, Sausville E, et al:
IAP-family protein survivin inhibits caspase activity and apoptosis
induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer
Res. 58:5315–5320. 1998.PubMed/NCBI
|
